GLP-1 Medications & Eating Disorders: What You Need to Know

GLP-1 medications (like Ozempic, Wegovy, and Mounjaro) are becoming increasingly popular for weight management—but if you’re living with or recovering from an eating disorder, proceed with caution. The below information is based on ANAD research and recommendations.

✨ These meds can reduce cravings, suppress appetite, and lead to rapid weight loss—which may sound appealing to someone struggling with food or body image. But here’s the reality:

🚨 Potential Risks for ED Recovery:

• Appetite suppression may disrupt hunger cues and regular eating patterns—critical pillars of recovery.

• Side effects like nausea or early fullness can trigger restrictive or purging behaviors.

• Weight loss and regain cycles may emotionally destabilize individuals in recovery.

• GLP-1 use is not FDA-approved for eating disorders, and long-term effects remain largely unknown.

• 
  

💬 As ANAD puts it: “Recovery involves being in tune with hunger cues and establishing a pattern of regular eating. GLP-1 medications may disrupt that progress in some people.”

If you're considering GLP-1 meds and have a history of an eating disorder (even if you’re in recovery), it’s essential to work with a multidisciplinary care team—physician, therapist, and dietitian—who truly understand eating disorders and your recovery goals.

Your recovery comes first. Always. 💛

🔗 Source: ANAD (National Association of Anorexia Nervosa and Associated Disorders)